Tags

Type your tag names separated by a space and hit enter

Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency.
Arch Neurol. 2008 Mar; 65(3):387-92.AN

Abstract

OBJECTIVE

To report the long-term results of early initiation of treatment of 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency.

DESIGN

Between 1988 and 2000, 12 newborns with PTPS deficiency who underwent early treatment at our hospital were identified. All patients received tetrahydrobiopterin replacement in a daily dosage between approximately 2 and 4 mg/kg. The dosages of levodopa replacement were 10 to 15 mg/kg/d, which is considerably higher than the typically recommended dosages of less than 7 mg/kg/d for patients aged younger than 2 years and 8 to 10 mg/kg/d for patients aged 2 years or older. Replacement with 5-hydroxytryptophan varied widely among patients.

SETTING

Taipei Veterans General Hospital. Patients Twelve newborns.

INTERVENTIONS

Treatment with tetrahydrobiopterin, levodopa, and 5-hydroxytryptophan. Main Outcome Measure IQ score.

RESULTS

The mean (SD) IQ score of our PTPS-deficient patients was 96.7 (9.7; range 86-119), which is considerably higher than previous reports of other populations of PTPS-deficient patients. All patients reached a normal IQ on high daily dosages of levodopa replacement, without developing apparent long-term levodopa-induced adverse effects. We also observed a correlation between long-term IQ score and genotype, birth weight, and age at initiation of treatment.

CONCLUSIONS

An effective newborn screening referral program and early initiation of appropriate therapy preserved the IQ scores of PTPS-deficient patients.

Authors+Show Affiliations

Insitute of Clinical Medicine, School of Medicine, Taipei, Taiwan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Journal Article

Language

eng

PubMed ID

18332253

Citation

Liu, Kai-Ming, et al. "Long-term Follow-up of Taiwanese Chinese Patients Treated Early for 6-pyruvoyl-tetrahydropterin Synthase Deficiency." Archives of Neurology, vol. 65, no. 3, 2008, pp. 387-92.
Liu KM, Liu TT, Lee NC, et al. Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency. Arch Neurol. 2008;65(3):387-92.
Liu, K. M., Liu, T. T., Lee, N. C., Cheng, L. Y., Hsiao, K. J., & Niu, D. M. (2008). Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency. Archives of Neurology, 65(3), 387-92. https://doi.org/10.1001/archneur.65.3.387
Liu KM, et al. Long-term Follow-up of Taiwanese Chinese Patients Treated Early for 6-pyruvoyl-tetrahydropterin Synthase Deficiency. Arch Neurol. 2008;65(3):387-92. PubMed PMID: 18332253.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Long-term follow-up of Taiwanese Chinese patients treated early for 6-pyruvoyl-tetrahydropterin synthase deficiency. AU - Liu,Kai-Ming, AU - Liu,Tze-Tze, AU - Lee,Ni-Chung, AU - Cheng,Ling-Yee, AU - Hsiao,Kwang-Jen, AU - Niu,Dau-Ming, PY - 2008/3/12/pubmed PY - 2008/5/9/medline PY - 2008/3/12/entrez SP - 387 EP - 92 JF - Archives of neurology JO - Arch Neurol VL - 65 IS - 3 N2 - OBJECTIVE: To report the long-term results of early initiation of treatment of 6-pyruvoyl-tetrahydropterin synthase (PTPS) deficiency. DESIGN: Between 1988 and 2000, 12 newborns with PTPS deficiency who underwent early treatment at our hospital were identified. All patients received tetrahydrobiopterin replacement in a daily dosage between approximately 2 and 4 mg/kg. The dosages of levodopa replacement were 10 to 15 mg/kg/d, which is considerably higher than the typically recommended dosages of less than 7 mg/kg/d for patients aged younger than 2 years and 8 to 10 mg/kg/d for patients aged 2 years or older. Replacement with 5-hydroxytryptophan varied widely among patients. SETTING: Taipei Veterans General Hospital. Patients Twelve newborns. INTERVENTIONS: Treatment with tetrahydrobiopterin, levodopa, and 5-hydroxytryptophan. Main Outcome Measure IQ score. RESULTS: The mean (SD) IQ score of our PTPS-deficient patients was 96.7 (9.7; range 86-119), which is considerably higher than previous reports of other populations of PTPS-deficient patients. All patients reached a normal IQ on high daily dosages of levodopa replacement, without developing apparent long-term levodopa-induced adverse effects. We also observed a correlation between long-term IQ score and genotype, birth weight, and age at initiation of treatment. CONCLUSIONS: An effective newborn screening referral program and early initiation of appropriate therapy preserved the IQ scores of PTPS-deficient patients. SN - 0003-9942 UR - https://wwww.unboundmedicine.com/medline/citation/18332253/Long_term_follow_up_of_Taiwanese_Chinese_patients_treated_early_for_6_pyruvoyl_tetrahydropterin_synthase_deficiency_ L2 - https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/archneur.65.3.387 DB - PRIME DP - Unbound Medicine ER -